Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS. MINOCYCLINE HYDROCHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1971
Medication labelWhy this: Advisory · dailymed-prescription
Minocycline hydrochloride extended-release tablets is indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies (14)]. To reduce the development of drug-resistant bacteria as well as to maintain the effectiveness of other antibacterial drugs, use minocycline hydrochloride extended-release tablets only as indicated [see Warnings and Precautions (5.12)].
- generic_name
- minocycline hydrochloride
- product_names
- Minocycline Hydrochloride
- ndc
- 67877-436, 67877-437, 67877-438, 67877-576, 67877-577, 67877-578, 67877-643, 67877-644, 67877-578-14, 67877-578-30, 67877-578-01, 67877-578-05, 67877-576-14, 67877-576-30, 67877-576-01, 67877-576-05, 67877-577-14, 67877-577-30, 67877-577-01, 67877-577-05, 67877-643-14, 67877-643-30, 67877-643-01, 67877-643-05, 67877-644-14, 67877-644-30, 67877-644-01, 67877-644-05, 67877-436-14, 67877-436-30, 67877-436-01, 67877-436-05, 67877-437-14, 67877-437-30, 67877-437-01, 67877-437-05, 67877-438-14, 67877-438-30, 67877-438-01, 67877-438-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en